Opinion: Without a plan to fight superbugs, the Cancer Moonshot will never achieve liftoff
Antimicrobial resistance is a threat to everyone. But cancer patients are particularly vulnerable.
Researchers at the National Institutes of Health recently outlined strategies to tackle President Biden’s Cancer Moonshot initiative, which aims to cut cancer deaths in half over the next 25 years. They made one glaring omission: a plan to combat drug-resistant superbugs.
The two public health crises — cancer and drug-resistant infections — are deeply intertwined. Patients with cancer are three times more likely to die of an infection than patients without the disease. Unless we quickly mobilize to fight superbugs, the Cancer Moonshot will never achieve liftoff.
What's Your Reaction?
